Genentech ups Parkinson's research with 23andMe collaboration
This article was originally published in Scrip
Executive Summary
Genentech, a subsidiary of Roche, is teaming up with personal genetics firm 23andMe to research new therapeutic targets for treating Parkinson's disease.